Table 3

 ABCG2 and MCM2 expression in tumours with pre operative chemotherapy

Serial NoAge/sexClinicopathological featuresChemotherapy information% of ABCG2 stained tumour cells% of MCM2 stained tumour cellsFollow up
M, male; F, female; y, years; m, months; LE, left eye; RE, right eye; BE, bilateral; PD, poorly differentiated; WD, well differentiated; MD, moderately differentiated; ON, optic nerve; Ch, choroidal; inv, invasion; Chemo, chemotherapy; preop, preoperative; postop, postoperative; TCC, transconjunctival cryopexy.
13y/MLE: PD, no invasion4 cycles of triple chemo400No recurrence in the enucleated eye
22y/MRE: WD, no invasion2 cycles of triple chemo600
32y/MBE: LE, MD, no invasion6 cycles of triple chemo200
49m/FRE: PD, no invasion4 cycles of triple chemo060
52y/MBE: RE, WD, focal Ch invasion2 cycles of preop chemo, postop 6 cycles triple chemo + TCC + TTT400
64m/MBE: RE, PD, no invasion2 cycles of triple chemo500